Trials / Terminated
TerminatedNCT01398852
Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia
Long Term Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Post-Refractive Corneal Ectasia
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to evaluate the long tern safety and effectiveness of cross-linking in eyes with keratoconus and ectasia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Riboflavin | Riboflavin is a solution that will be delivered to the treatment area |
| DEVICE | VEGA UV-A Illumination System | This is a portable electronic device designed to deliver a dose of UV-A light to the treatment area |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-07-21
- Last updated
- 2022-06-29
- Results posted
- 2013-03-04
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01398852. Inclusion in this directory is not an endorsement.